Fructose-enriched diet induces inflammation and reduces antioxidative defense in visceral adipose tissue of young female rats

Eur J Nutr. 2017 Feb;56(1):151-160. doi: 10.1007/s00394-015-1065-0. Epub 2015 Oct 3.

Abstract

Purpose: The consumption of refined, fructose-enriched food continuously increases and has been linked to development of obesity, especially in young population. Low-grade inflammation and increased oxidative stress have been implicated in the pathogenesis of obesity-related disorders including type 2 diabetes. In this study, we examined alterations in inflammation and antioxidative defense system in the visceral adipose tissue (VAT) of fructose-fed young female rats, and related them to changes in adiposity and insulin sensitivity.

Methods: We examined the effects of 9-week fructose-enriched diet applied immediately after weaning on nuclear factor κB (NF-κB) intracellular distribution, and on the expression of pro-inflammatory cytokines (IL-1β and TNFα) and key antioxidative enzymes in the VAT of female rats. Insulin signaling in the VAT was evaluated at the level of insulin receptor substrate-1 (IRS-1) protein and its inhibitory phosphorylation on Ser307.

Results: Fructose-fed rats had increased VAT mass along with increased NF-κB nuclear accumulation and elevated IL-1β, but not TNFα expression. The protein levels of antioxidative defense enzymes, mitochondrial manganese superoxide dismutase 2, and glutathione peroxidase, were reduced, while the protein content of IRS-1 and its inhibitory phosphorylation were not altered by fructose diet.

Conclusions: The results suggest that fructose overconsumption-related alterations in pro-inflammatory markers and antioxidative capacity in the VAT of young female rats can be implicated in the development of adiposity, but do not affect inhibitory phosphorylation of IRS-1.

Keywords: Female rats; Fructose diet; Inflammation; NF-κB; Oxidative stress; Visceral adipose tissue.

MeSH terms

  • Adiposity / drug effects
  • Animals
  • Antioxidants / metabolism*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diet
  • Female
  • Fructose / administration & dosage
  • Fructose / adverse effects*
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Inflammation / etiology
  • Inflammation / pathology*
  • Insulin Receptor Substrate Proteins / genetics
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Intra-Abdominal Fat / drug effects*
  • Intra-Abdominal Fat / metabolism
  • Mitochondria / enzymology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Obesity / complications
  • Obesity / physiopathology
  • Oxidative Stress / drug effects
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antioxidants
  • Insulin Receptor Substrate Proteins
  • Interleukin-1beta
  • Irs1 protein, rat
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • Fructose
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • superoxide dismutase 2